fig2

From: Challenges in the management of MetALD after liver transplantation

Figure 2. Management workflow of comorbidities in post-LT setting^{[17,70,91-95]}. BMI: Body mass index; GLP1-RAs: glucagon-like peptide-1 receptor agonists; LT: liver transplantation; eGFR: estimated glomerular filtration rate; SGLT2: sodium-glucose cotransporter-2; CCBs: calcium channel blockers; ACE-I: angiotensin converting enzyme-inhibitor; ARBs: angiotensin receptor blockers; mTOR: mammalian target of rapamycin; EtG: ethyl glucuronide; PEth: phosphatidylethanol; AUD: alcohol use disorder.

Metabolism and Target Organ Damage

ISSN 2769-6375 (Online)

editorialoffice@mtodjournal.net

Navigation

Sitemap

Navigation

Sitemap

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

partners@oaepublish.com

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service

Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.